Does the media refer more to BRKR or MTD?

In the previous week, Mettler-Toledo International had 10 more articles in the media than Bruker. MarketBeat recorded 40 mentions for Mettler-Toledo International and 30 mentions for Bruker. Bruker's average media sentiment score of 0.73 beat Mettler-Toledo International's score of 0.65 indicating that Bruker is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bruker 10 Very Positive mention(s) 3 Positive mention(s) 13 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 13 Very Positive mention(s) 5 Positive mention(s) 15 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to RGEN or MTD?

In the previous week, Mettler-Toledo International had 32 more articles in the media than Repligen. MarketBeat recorded 40 mentions for Mettler-Toledo International and 8 mentions for Repligen. Repligen's average media sentiment score of 0.87 beat Mettler-Toledo International's score of 0.65 indicating that Repligen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Repligen 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 13 Very Positive mention(s) 5 Positive mention(s) 15 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to TECH or MTD?

In the previous week, Mettler-Toledo International had 24 more articles in the media than Bio-Techne. MarketBeat recorded 40 mentions for Mettler-Toledo International and 16 mentions for Bio-Techne. Bio-Techne's average media sentiment score of 0.66 beat Mettler-Toledo International's score of 0.65 indicating that Bio-Techne is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Techne 6 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 13 Very Positive mention(s) 5 Positive mention(s) 15 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to A or MTD?

In the previous week, Mettler-Toledo International had 25 more articles in the media than Agilent Technologies. MarketBeat recorded 40 mentions for Mettler-Toledo International and 15 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 0.93 beat Mettler-Toledo International's score of 0.65 indicating that Agilent Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 10 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 13 Very Positive mention(s) 5 Positive mention(s) 15 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Mettler-Toledo International (MTD) Competitors

$1,757.55 +6.17 (+0.35%)

As of 03:26 PM Eastern

Compare

MTD vs. BRKR, RGEN, TECH, A, and BIO

Should you buy Mettler-Toledo International stock or one of its competitors? Mettler-Toledo International's main competitors and comparable companies include Bruker (BRKR), Repligen (RGEN), Bio-Techne (TECH), Agilent Technologies (A), and Bio-Rad Laboratories (BIO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Mettler-Toledo International compare to Bruker?

Bruker (NASDAQ:BRKR) and Mettler-Toledo International (NYSE:MTD) are both large-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.

Mettler-Toledo International has higher revenue and earnings than Bruker. Bruker is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bruker	$3.44B	2.77	-$8.60M	-$1.10	N/A
Mettler-Toledo International	$4.03B	8.64	$869.19M	$46.15	37.91

Bruker currently has a consensus price target of $60.57, indicating a potential downside of 2.68%. Mettler-Toledo International has a consensus price target of $1,595.77, indicating a potential downside of 8.80%. Given Bruker's stronger consensus rating and higher probable upside, analysts plainly believe Bruker is more favorable than Mettler-Toledo International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bruker	1 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.57
Mettler-Toledo International	1 Sell rating(s)	8 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.33

79.5% of Bruker shares are held by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are held by institutional investors. 27.2% of Bruker shares are held by company insiders. Comparatively, 0.7% of Mettler-Toledo International shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Mettler-Toledo International had 10 more articles in the media than Bruker. MarketBeat recorded 40 mentions for Mettler-Toledo International and 30 mentions for Bruker. Bruker's average media sentiment score of 0.73 beat Mettler-Toledo International's score of 0.65 indicating that Bruker is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bruker	10 Very Positive mention(s)	3 Positive mention(s)	13 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Mettler-Toledo International	13 Very Positive mention(s)	5 Positive mention(s)	15 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Mettler-Toledo International has a net margin of 22.25% compared to Bruker's net margin of -3.82%. Mettler-Toledo International's return on equity of 15,012.71% beat Bruker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bruker	-3.82%	13.76%	5.47%
Mettler-Toledo International	22.25%	15,012.71%	25.41%

Bruker has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.16, suggesting that its share price is 16% more volatile than the broader market.

Summary

Mettler-Toledo International beats Bruker on 11 of the 17 factors compared between the two stocks.

How does Mettler-Toledo International compare to Repligen?

Repligen (NASDAQ:RGEN) and Mettler-Toledo International (NYSE:MTD) are both large-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations.

97.6% of Repligen shares are held by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are held by institutional investors. 0.6% of Repligen shares are held by insiders. Comparatively, 0.7% of Mettler-Toledo International shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Mettler-Toledo International had 32 more articles in the media than Repligen. MarketBeat recorded 40 mentions for Mettler-Toledo International and 8 mentions for Repligen. Repligen's average media sentiment score of 0.87 beat Mettler-Toledo International's score of 0.65 indicating that Repligen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Repligen	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Mettler-Toledo International	13 Very Positive mention(s)	5 Positive mention(s)	15 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Repligen presently has a consensus target price of $178.57, indicating a potential upside of 2.64%. Mettler-Toledo International has a consensus target price of $1,595.77, indicating a potential downside of 8.80%. Given Repligen's stronger consensus rating and higher probable upside, equities analysts clearly believe Repligen is more favorable than Mettler-Toledo International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Repligen	1 Sell rating(s)	3 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.83
Mettler-Toledo International	1 Sell rating(s)	8 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.33

Mettler-Toledo International has a net margin of 22.25% compared to Repligen's net margin of -1.47%. Mettler-Toledo International's return on equity of 15,012.71% beat Repligen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Repligen	-1.47%	5.49%	3.93%
Mettler-Toledo International	22.25%	15,012.71%	25.41%

Mettler-Toledo International has higher revenue and earnings than Repligen. Repligen is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Repligen	$738.26M	15.06	$48.89M	-$0.21	N/A
Mettler-Toledo International	$4.03B	8.64	$869.19M	$46.15	37.91

Repligen has a beta of 1.11, suggesting that its share price is 11% more volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.16, suggesting that its share price is 16% more volatile than the broader market.

Summary

Mettler-Toledo International beats Repligen on 9 of the 17 factors compared between the two stocks.

How does Mettler-Toledo International compare to Bio-Techne?

Bio-Techne (NASDAQ:TECH) and Mettler-Toledo International (NYSE:MTD) are both large-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.

Bio-Techne currently has a consensus price target of $68.92, suggesting a potential downside of 5.35%. Mettler-Toledo International has a consensus price target of $1,595.77, suggesting a potential downside of 8.80%. Given Bio-Techne's higher possible upside, equities research analysts clearly believe Bio-Techne is more favorable than Mettler-Toledo International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bio-Techne	1 Sell rating(s)	14 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.12
Mettler-Toledo International	1 Sell rating(s)	8 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.33

Bio-Techne has a beta of 1.29, meaning that its share price is 29% more volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.16, meaning that its share price is 16% more volatile than the broader market.

Mettler-Toledo International has higher revenue and earnings than Bio-Techne. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bio-Techne	$1.23B	9.31	$181.86M	$1.15	63.32
Mettler-Toledo International	$4.03B	8.64	$869.19M	$46.15	37.91

In the previous week, Mettler-Toledo International had 24 more articles in the media than Bio-Techne. MarketBeat recorded 40 mentions for Mettler-Toledo International and 16 mentions for Bio-Techne. Bio-Techne's average media sentiment score of 0.66 beat Mettler-Toledo International's score of 0.65 indicating that Bio-Techne is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bio-Techne	6 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Mettler-Toledo International	13 Very Positive mention(s)	5 Positive mention(s)	15 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Mettler-Toledo International has a net margin of 22.25% compared to Bio-Techne's net margin of 14.00%. Mettler-Toledo International's return on equity of 15,012.71% beat Bio-Techne's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bio-Techne	14.00%	11.56%	9.40%
Mettler-Toledo International	22.25%	15,012.71%	25.41%

98.9% of Bio-Techne shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 1.3% of Bio-Techne shares are owned by company insiders. Comparatively, 0.7% of Mettler-Toledo International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Mettler-Toledo International beats Bio-Techne on 9 of the 17 factors compared between the two stocks.

How does Mettler-Toledo International compare to Agilent Technologies?

Agilent Technologies (NYSE:A) and Mettler-Toledo International (NYSE:MTD) are both large-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, media sentiment, analyst recommendations and earnings.

Agilent Technologies has higher revenue and earnings than Mettler-Toledo International. Agilent Technologies is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilent Technologies	$6.95B	7.22	$1.30B	$5.08	35.04
Mettler-Toledo International	$4.03B	8.64	$869.19M	$46.15	37.91

Agilent Technologies has a beta of 1.24, indicating that its share price is 24% more volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.16, indicating that its share price is 16% more volatile than the broader market.

95.1% of Mettler-Toledo International shares are held by institutional investors. 0.7% of Mettler-Toledo International shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Mettler-Toledo International had 25 more articles in the media than Agilent Technologies. MarketBeat recorded 40 mentions for Mettler-Toledo International and 15 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 0.93 beat Mettler-Toledo International's score of 0.65 indicating that Agilent Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilent Technologies	10 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Mettler-Toledo International	13 Very Positive mention(s)	5 Positive mention(s)	15 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Mettler-Toledo International has a net margin of 22.25% compared to Agilent Technologies' net margin of 19.53%. Mettler-Toledo International's return on equity of 15,012.71% beat Agilent Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilent Technologies	19.53%	24.45%	13.09%
Mettler-Toledo International	22.25%	15,012.71%	25.41%

Agilent Technologies currently has a consensus target price of $181.45, indicating a potential upside of 1.93%. Mettler-Toledo International has a consensus target price of $1,595.77, indicating a potential downside of 8.80%. Given Agilent Technologies' stronger consensus rating and higher probable upside, equities research analysts clearly believe Agilent Technologies is more favorable than Mettler-Toledo International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilent Technologies	0 Sell rating(s)	4 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.82
Mettler-Toledo International	1 Sell rating(s)	8 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

Mettler-Toledo International beats Agilent Technologies on 9 of the 16 factors compared between the two stocks.

How does Mettler-Toledo International compare to Bio-Rad Laboratories?

Bio-Rad Laboratories (NYSE:BIO) and Mettler-Toledo International (NYSE:MTD) are both large-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

In the previous week, Mettler-Toledo International had 24 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 40 mentions for Mettler-Toledo International and 16 mentions for Bio-Rad Laboratories. Mettler-Toledo International's average media sentiment score of 0.65 beat Bio-Rad Laboratories' score of 0.64 indicating that Mettler-Toledo International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bio-Rad Laboratories	5 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Mettler-Toledo International	13 Very Positive mention(s)	5 Positive mention(s)	15 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Bio-Rad Laboratories presently has a consensus price target of $366.67, suggesting a potential downside of 5.13%. Mettler-Toledo International has a consensus price target of $1,595.77, suggesting a potential downside of 8.80%. Given Bio-Rad Laboratories' higher probable upside, analysts clearly believe Bio-Rad Laboratories is more favorable than Mettler-Toledo International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bio-Rad Laboratories	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20
Mettler-Toledo International	1 Sell rating(s)	8 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.33

Bio-Rad Laboratories has a net margin of 39.45% compared to Mettler-Toledo International's net margin of 22.25%. Mettler-Toledo International's return on equity of 15,012.71% beat Bio-Rad Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bio-Rad Laboratories	39.45%	3.58%	2.51%
Mettler-Toledo International	22.25%	15,012.71%	25.41%

Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bio-Rad Laboratories	$2.58B	4.00	$759.90M	$37.97	10.18
Mettler-Toledo International	$4.03B	8.64	$869.19M	$46.15	37.91

65.2% of Bio-Rad Laboratories shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 30.3% of Bio-Rad Laboratories shares are owned by insiders. Comparatively, 0.7% of Mettler-Toledo International shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Bio-Rad Laboratories has a beta of 1.06, indicating that its stock price is 6% more volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.16, indicating that its stock price is 16% more volatile than the broader market.

Summary

Mettler-Toledo International beats Bio-Rad Laboratories on 13 of the 16 factors compared between the two stocks.

Get Mettler-Toledo International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MTD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MTD vs. The Competition

Export

Metric	Mettler-Toledo International	Life Sciences Tools & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$34.96B	$11.24B	$7.88B	$23.61B
Dividend Yield	N/A	1.44%	2.47%	3.73%
P/E Ratio	38.09	53.32	34.20	30.41
Price / Sales	8.68	7.42	8.48	3.40
Price / Cash	35.50	27.65	22.22	15.97
Price / Book	450.65	4.60	4.43	3.76
Net Income	$869.19M	$57.48B	$3.50B	$1.08B
7 Day Performance	2.00%	0.01%	-0.94%	-0.60%
1 Month Performance	13.30%	-1.31%	-4.05%	1.08%
1 Year Performance	21.52%	22.56%	1.43%	6.72%

Mettler-Toledo International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MTD Mettler-Toledo International	2.6836 of 5 stars	$1,757.55 +0.4%	$1,595.77 -9.2%	+22.1%	$34.96B	$4.03B	38.09	18,100	News Coverage Earnings Report Analyst Forecast Insider Trade
BRKR Bruker	2.6489 of 5 stars	$55.69 -2.4%	$59.43 +6.7%	+52.6%	$9.45B	$3.44B	N/A	11,085	Earnings Report Gap Up
RGEN Repligen	2.4023 of 5 stars	$172.95 -2.3%	$178.57 +3.3%	+19.4%	$10.42B	$738.26M	90.53	2,000
TECH Bio-Techne	2.2928 of 5 stars	$72.67 +0.0%	$68.92 -5.2%	+26.7%	$11.40B	$1.22B	42.26	3,000	Earnings Report
A Agilent Technologies	3.9577 of 5 stars	$172.01 -1.6%	$181.45 +5.5%	+21.6%	$49.30B	$7.37B	33.86	18,100

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MTD) was last updated on 11/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mettler-Toledo International (MTD) Competitors

MTD vs. BRKR, RGEN, TECH, A, and BIO

How does Mettler-Toledo International compare to Bruker?

Summary

How does Mettler-Toledo International compare to Repligen?

Summary

How does Mettler-Toledo International compare to Bio-Techne?

Summary

How does Mettler-Toledo International compare to Agilent Technologies?

Summary

How does Mettler-Toledo International compare to Bio-Rad Laboratories?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MTD vs. The Competition

Mettler-Toledo International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Mettler-Toledo International (MTD) Competitors

MTD vs. BRKR, RGEN, TECH, A, and BIO

How does Mettler-Toledo International compare to Bruker?

Which has higher earnings and valuation, BRKR or MTD?

Do analysts prefer BRKR or MTD?

Do institutionals and insiders believe in BRKR or MTD?

Does the media refer more to BRKR or MTD?

Is BRKR or MTD more profitable?

Which has more volatility and risk, BRKR or MTD?

Summary

How does Mettler-Toledo International compare to Repligen?

Do insiders and institutionals believe in RGEN or MTD?

Does the media refer more to RGEN or MTD?

Do analysts prefer RGEN or MTD?

Is RGEN or MTD more profitable?

Which has stronger earnings & valuation, RGEN or MTD?

Which has more risk & volatility, RGEN or MTD?

Summary

How does Mettler-Toledo International compare to Bio-Techne?

Do analysts recommend TECH or MTD?

Which has more risk and volatility, TECH or MTD?

Which has higher earnings and valuation, TECH or MTD?

Does the media refer more to TECH or MTD?

Is TECH or MTD more profitable?

Do insiders and institutionals hold more shares of TECH or MTD?

Summary

How does Mettler-Toledo International compare to Agilent Technologies?

Which has higher valuation & earnings, A or MTD?

Which has more volatility and risk, A or MTD?

Do institutionals & insiders believe in A or MTD?

Does the media refer more to A or MTD?

Is A or MTD more profitable?

Do analysts recommend A or MTD?

Summary

How does Mettler-Toledo International compare to Bio-Rad Laboratories?

Does the media refer more to BIO or MTD?

Do analysts recommend BIO or MTD?

Is BIO or MTD more profitable?

Which has stronger earnings & valuation, BIO or MTD?

Do institutionals and insiders hold more shares of BIO or MTD?

Which has more volatility & risk, BIO or MTD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MTD vs. The Competition

Mettler-Toledo International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools